Literature DB >> 16443228

Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action.

Angus Bell1, Paul Monaghan, Antony P Page.   

Abstract

Immunophilin is the collective name given to the cyclophilin and FK506-binding protein families. As the name suggests, these include the major binding proteins of certain immunosuppressive drugs: cyclophilins for the cyclic peptide cyclosporin A and FK506-binding proteins for the macrolactones FK506 and rapamycin. Both families, although dissimilar in sequence, possess peptidyl-prolyl cis-trans isomerase activity in vitro and can play roles in protein folding and transport, RNA splicing and the regulation of multi-protein complexes in cells. In addition to enzymic activity, many immunophilins act as molecular chaperones. This property may be conferred by the isomerase domain and/or by additional domains. Recent years have seen a great increase in the number of known immunophilin genes in parasitic protozoa and helminths and in many cases their products have been characterised biochemically and their temporal and spatial expression patterns have been examined. Some of these genes represent novel types: one example is a Toxoplasma gondii gene encoding a protein with both cyclophilin and FK506-binding protein domains. Likely roles in protein folding and oligomerisation, RNA splicing and sexual differentiation have been suggested for parasite immunophilins. In addition, unexpected roles in parasite virulence (Mip FK506-binding protein of Trypanosoma cruzi) and host immuno-modulation (e.g. 18-kDa cyclophilin of T. gondii) have been established. Furthermore, in view of the potent antiparasitic activities of cyclosporins, macrolactones and non-immunosuppressive derivatives of these compounds, immunophilins may mediate drug action and/or may themselves represent potential drug targets. Investigation of the mechanisms of action of these agents may lead to the design of potent and selective antimalarial and other antiparasitic drugs. This review discusses the properties of immunophilins in parasites and the 'animal model'Caenorhabditis elegans and relates these to our understanding of the roles of these proteins in cellular biochemistry, host-parasite interaction and the antiparasitic mechanisms of the drugs that bind to them.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16443228     DOI: 10.1016/j.ijpara.2005.11.003

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  46 in total

1.  Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells.

Authors:  Hany M Ibrahim; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

2.  Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces Bradyzoite conversion in a CCR5-dependent manner.

Authors:  Hany M Ibrahim; Hiroshi Bannai; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 3.  Cyclophilin D in mitochondrial pathophysiology.

Authors:  Valentina Giorgio; Maria Eugenia Soriano; Emy Basso; Elena Bisetto; Giovanna Lippe; Michael A Forte; Paolo Bernardi
Journal:  Biochim Biophys Acta       Date:  2009-12-21

Review 4.  Microbial cyclophilins: specialized functions in virulence and beyond.

Authors:  Maria Dimou; Anastasia Venieraki; Panagiotis Katinakis
Journal:  World J Microbiol Biotechnol       Date:  2017-08-08       Impact factor: 3.312

Review 5.  Towards identifying novel anti-Eimeria agents: trace elements, vitamins, and plant-based natural products.

Authors:  Frank Wunderlich; Saleh Al-Quraishy; Holger Steinbrenner; Helmut Sies; Mohamed A Dkhil
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

6.  Inhibitory effect of cyclophilin A from the hard tick Haemaphysalis longicornis on the growth of Babesia bovis and Babesia bigemina.

Authors:  Hiroki Maeda; Damdinsuren Boldbaatar; Kodai Kusakisako; Remil Linggatong Galay; Kyaw Min Aung; Rika Umemiya-Shirafuji; Masami Mochizuki; Kozo Fujisaki; Tetsuya Tanaka
Journal:  Parasitol Res       Date:  2013-03-27       Impact factor: 2.289

7.  The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice.

Authors:  T Tiepolo; A Angelin; E Palma; P Sabatelli; L Merlini; L Nicolosi; F Finetti; P Braghetta; G Vuagniaux; J-M Dumont; C T Baldari; P Bonaldo; P Bernardi
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

8.  Structural, biochemical, and in vivo characterization of the first virally encoded cyclophilin from the Mimivirus.

Authors:  Vu Thai; Patricia Renesto; C Andrew Fowler; Darin J Brown; Tara Davis; Wanjun Gu; David D Pollock; Dorothee Kern; Didier Raoult; Elan Z Eisenmesser
Journal:  J Mol Biol       Date:  2007-08-29       Impact factor: 5.469

9.  Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.

Authors:  Wai-Lok Yau; Thierry Blisnick; Jean-François Taly; Manuela Helmer-Citterich; Cordelia Schiene-Fischer; Olivier Leclercq; Jing Li; Dirk Schmidt-Arras; Miguel A Morales; Cedric Notredame; Daniel Romo; Philippe Bastin; Gerald F Späth
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

10.  In silico analysis of the cyclophilin repertoire of apicomplexan parasites.

Authors:  Jürgen Krücken; Gisela Greif; Georg von Samson-Himmelstjerna
Journal:  Parasit Vectors       Date:  2009-06-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.